학술논문
Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non–Small-Cell Lung Cancer and High PD-L1 Tumor Expression
Document Type
Article
Author
Source
In Clinical Lung Cancer September 2020 21(5):e366-e379
Subject
Language
ISSN
1525-7304